Inventor · Snohomish, WA, US

Brian R. Kovacevich

70Patents
18h-index
61Co-inventors
87Inventor score

Filing activity: Jul 9, 1993 → Jan 7, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US6803453B1 Antibodies associated with alterations in bone density Physics 86 Expired
US7935340B2 Antibodies to IL-6 and use thereof Chemistry; Metallurgy 82 Active
US6489445B1 Polypeptides associated with alterations in bone density Physics 81 Expired
US6395511B1 Nucleic acids encoding a novel family of TGF-&bgr; binding proteins from humans Physics 79 Expired
US6495736B1 Compositions and methods for increasing bone mineralization Physics 73 Expired
US5356801A Recombinant DNA encoding a desulfurization biocatalyst Chemistry; Metallurgy 60 Expired
US7192583B2 Methods for modulating bone mineralization Physics 56 Expired
US8323649B2 Antibodies to IL-6 and use thereof Emerging Cross-Sectional Technologies 54 Active
US8062864B2 Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies Chemistry; Metallurgy 50 Active
US7572899B2 Compositions and methods for increasing bone mineralization Physics 50 Expired
US8178101B2 Use of anti-IL-6 antibodies having specific binding properties to treat cachexia Chemistry; Metallurgy 48 Active
US7758858B2 Antibodies associated with alterations in bone density Physics 40 Expired
US9255154B2 Anti-PCSK9 antibodies and use thereof Physics 32 Active
US9085615B2 Antibodies to IL-6 to inhibit or treat inflammation Emerging Cross-Sectional Technologies 24 Active
US9452227B2 Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments Emerging Cross-Sectional Technologies 22 Active
US9708393B2 Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers Emerging Cross-Sectional Technologies 18 Active
US9855332B2 Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels Emerging Cross-Sectional Technologies 18 Active
US9745373B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 18 Active
US9884912B2 Antibodies to IL-6 and use thereof Chemistry; Metallurgy 15 Active
US10066009B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 14 Active
US10214582B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 12 Active
US10266587B2 Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers Emerging Cross-Sectional Technologies 12 Active
US10179809B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 12 Active
US10189895B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 12 Active
US10208112B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 12 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.